Brief: InDex Pharmaceuticals Announces Positive Results From PK Study With Cobitolimod
March 15 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* INDEX PHARMACEUTICALS ANNOUNCES POSITIVE RESULTS FROM A
PHARMACOKINETIC (PK) STUDY WITH COBITOLIMOD
Source text for Eikon: ID:nWkrbYbXnX
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen